Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05879159 · ClinicalTrials.gov registry record · NA
Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection
A NA study of Liver, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT05879159 is a NA study of Liver that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 36 participants, above the 14-participant average among 3 other Liver trials with a reported enrollment target (157% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05879159, a NA study of Liver, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-10-05 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05879159
The ClinicalTrials.gov registry entry for NCT05879159 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 14-participant average among 3 other Liver trials with a reported enrollment target (157% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver appearing as the primary indexed condition, and to 1 intervention - of which Questionnaires is the first listed.
NCT05879159 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT05879159 about?
NCT05879159 is a clinical study titled "Accelerated Recovery After MIS Hepatectomy (ARAMIS Hep) to Support Early Discharge for Patients Undergoing Minimally Invasive Liver Resection". To learn if an accelerated recovery program can shorten the length of hospital stay in patients having minimally invasive liver surgery.
What is the current status of trial NCT05879159?
This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2023-10-05. Estimated completion is 2027-02-01.
What conditions does trial NCT05879159 study?
This clinical trial studies the following conditions: Liver.
What interventions are being tested in trial NCT05879159?
The interventions under investigation include: Questionnaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT05879159?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05879159 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis
RECRUITING · NA
-
Augmented Reality Real-Time Guidance for MRI-Guided Interventions
RECRUITING · NA
-
Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.